Clinical impact of molecular breast imaging as adjunct diagnostic modality in evaluation of indeterminate breast abnormalities and unresolved diagnostic concerns

Improvements in molecular breast imaging (MBI) have increased the use of MBI as adjunct diagnostic modality and alternative to MRI. We aimed to assess the value of MBI in patients with equivocal breast lesions on conventional imaging, especially in terms of its ability to rule out malignancy. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: van Loevezijn, Ariane A., Corion, Christinne L.S., Zeillemaker, Anneke M., Wijers, Lidy M.H., Smithuis, Robin H.M., Valdés Olmos, Renato A., van der Hage, Jos A., de Geus-Oei, Lioe-Fee, Benard, Menno, Pereira Arias-Bouda, Lenka M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171295/
https://www.ncbi.nlm.nih.gov/pubmed/36897051
http://dx.doi.org/10.1097/MNM.0000000000001684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171295/
https://www.ncbi.nlm.nih.gov/pubmed/36897051
http://dx.doi.org/10.1097/MNM.0000000000001684

Ejemplares similares